Gas-chromatographic study on the stereoselectivity of deprenyl metabolism

Journal of Pharmaceutical and Biomedical Analysis

Volumn 17, Issue 4-5, 1998, Pages 725-731

  Tarjanyi Zs ^a,b,e   Kalasz H ^a   Szebeni, G ^b   Hollosi I ^c   Bathori M ^d   Furst S ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b Chinoin Pharmaceutical and Chemical Works Ltd   (Hungary)

^c Natl Inst of Phys Educ/Sports   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

^e Zeneca Hungary   (Hungary)

Author keywords

(+) Deprenyl metabolism; ( ) Deprenyl metabolism; Efferent metabolites; Phenylacetone

Indexed keywords

AMPHETAMINE; DRUG METABOLITE; METHAMPHETAMINE; PHENYLACETONE; SELEGILINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; DRUG METABOLISM; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; STEREOCHEMISTRY;

AMPHETAMINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METHAMPHETAMINE; MONOAMINE OXIDASE INHIBITORS; NEUROPROTECTIVE AGENTS; SELEGILINE; STEREOISOMERISM;

EID: 0032146506     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(97)00227-6     Document Type: Article

References (26)

1. [1] W. Birkmayer, P. Riderer, M.B.H. Youdim, Clin. Neuropharmacol. 5 (1982) 195-230.
2. [2] The Parkinson Study Group, New Engl. J. Med. 321 (1989) 1364-1371.
3. [3] K. Magyar, L. Tothfalusi, Pol. J. Pharmacol. Pharm. 36 (1984) 373-384.
4. [4] K. Michaelis, J. Waitzinger, U. Agvez, Z. Salama, H. Plettenburg, H.H. Jager, Pharmacol. Res. 10 (1993) S331.
5. [5] T. Cserhati, K. Magyar, J. Biochem. Biophys. Methods 24 (1992) 249-264.
6. [6] E.H. Heinonen, M.I. Anttila, R.A.S. Lammintausta, in I. Szelényi (Ed.), Inhibitors of Monoamine Oxidase B, Birkhauser, Basel, 1992, pp. 201-213.
7. [7] E. Szoko, H. Kalasz, L. Kerecsen, K. Magyar, Pol. J. Pharmacol. Pharm. 36 (1984) 413-421.
8. [8] H. Kalasz, L. Kerecsen, J. Knoll, J. Pucsok, J. Chromatogr. 499 (1990) 589-599.
9. [9] J.S. Fowler, R.R. MacGregor, A.P. Wolf, et al., Science 236 (1987) 481-485.
10. [10] C.J. Bench, G.W. Price, A.A. Lammerstma, et al., Eur. J. Clin. Pharmacol. 40 (1991) 169-173.
11. [11] H. Kalasz, J. High Resol. Chromatogr. Chromatogr. Commun. 6 (1983) 4950.
12. [12] H. Kalasz, L. Kerecsen, B. Matkovics, I. Hollosi, in H. Kalasz, L.S. Ettre (Eds.), Chromatography '85, Akademiai Kiado, Budapest, 1986, pp. 129-134.
13. [13] Zs. Tarjanyi, H. Kalasz, F. Darvas, L. Kerecsen, K. Valko, J. Pucsok, in H. Kalasz, L.S. Ettre, J. Pick (Eds.), New Approaches in Chromatography '93, Fekete Sas Kiado, Budapest, 1993, pp. 243-258.
14. [14] G. Szebeni, J. Lengyel, G. Szekacs, K. Magyar, J. Gaal, I. Szatmari, Acta Physiol. Hung. 83 (1995) 135-141.
15. [15] K. Magyar, J. Knoll, Pol. J. Pharmacol. Pharm. 29 (1977) 233-246.
16. [16] G. Engeberg, T. Elebring, H. Nissbrandt, J. Pharmacol. Exp. Ther. 259 (1991) 841-847.
17. [17] E.H. Heinonen, R. Lammintausta, Acta Neurol. Scand. 84 (Suppl. 44) (1991) 59.
18. [18] J. Knoll, I. Miklya, Life Sci. 56 (1995) 611-620.
19. [19] E.H. Heinonen, V. Myllyla, K. Sotaniemi, L. Lammintausta, J.S. Salonen, M. Anttila, M. Savijarvi, M. Kotila, U.K. Rinne, Acta Neurol. Scand. 80 (1989) 93-99.
20. [20] J.I. Salach, K. Detmer, M.B. Youdim, Mol. Pharmacol. 16 (1979) 234-241.
21. [21] J.E. Meeker, P.C. Reynolds, J. Anal. Toxicol. 14 (1990) 330-331.
22. [22] E. Szoko, K. Magyar, Int. J. Pharm. Adv. 1 (1996) 320-327.
23. [23] K. Magyar, J. Lengyel, I. Szathmari and J. Gaal, in P.M. Yu, K.F. Tripton, A.A. Boulton (Eds.), Progress in Brain Research, vol. 106, Elsevier, Amsterdam, 1995, pp. 143-153.
24. [24] T. Yoshida, T. Oguro, Y. Kurolwa, Xenobiotica 17 (1987) 957-963.
25. [25] M. Weli, B.B. Hook, B. Lindeke, Acta Pharm. Suec. 22 (1985) 249-264.
26. [26] M.-C. Carrillo, S. Kanai, M. Nokubo, G.O. Ivy, Y. Sato, K. Kitani, Exp. Neurol. 116 (1992) 286-294.